HIV/AIDS

Displaying 1 - 2 of 2

Study examines HIV drug’s potential to treat Alzheimer’s

A drug used to treat and prevent HIV/AIDS is showing promise as a potential therapy for Alzheimer’s disease, and Vanderbilt University biochemist F. Peter Guengerich, PhD, is aiding efforts to make this approach to improving memory and cognitive function even better.

Related Categories: 
Health and Medicine Alzheimer's Disease department of biochemistry HIV/AIDS Journal of Medicinal Chemistry memory Peter Guengerich Research

A “public” target for HIV

Individuals produce unique sets of antibodies in response to HIV infection. That diversity — and the ability of the human immunodeficiency virus to rapidly change its protein coat to avoid detection — has stymied efforts to develop an anti-HIV vaccine.

Related Categories: 
Health and Medicine Gates Foundation HIV HIV/AIDS Ivelin Georgiev NCATS NHLBI NIAID NIGMS NIH pathology microbiology and immunology Vaccine Vanderbilt Vaccine Center